Jan. 26 Quick Takes: Sanofi to manufacture more than 100M doses of Comirnaty; plus Qiming, Nirogy, Takeda-Evozyne and Vir 

Under a new deal with Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), Sanofi (Euronext:SAN; NASDAQ:SNY) will produce more than 100 million doses of COVID-19 vaccine Cormirnaty in Europe in 2021. Sanofi spokesperson Nicolas Kressmann said initial supplies will be delivered from its Frankfurt facilities in August, and that the deal will not impact development of Sanofi’s COVID-19 vaccine development programs. 

In an emailed statement to BioCentury, Pfizer spokesperson Eamonn Nolan said, “Pfizer and BioNTech have been identifying ways to increase the supply of our COVID-19 vaccine, which include expanding our manufacturing facilities and adding more suppliers and contract manufacturers to our supply chain. The support from Sanofi is just one of these efforts.” ...